Fyodor Biotechnologies

About:

Fyodor Biotechnologies is a medical device company.

Top Investors: National Science Foundation, 500 Global, The Investment Collective

Description:

Fyodor is a privately held medical device company whose mission is to develop and commercialize novel medical diagnostic tests that address unmet needs in Nigeria and emerging economies. In response to the large proportion of malaria that is managed at home and in all healthcare settings, Fyodor has developed the Urine Malaria TestTM (UMT) – the first ever non-blood (one-step, no blood, no reagents, no equipment, visually read) rapid test that tells in 25 minutes or less if a fever is due to malaria or not. It removes the complexity, pain and risks associated with a blood test.

Total Funding Amount:

$1.47M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2008-01-01

Contact Email:

fyodor(AT)fyodorbio.com

Founders:

Eddy Agbo

Number of Employees:

1-10

Last Funding Date:

2018-07-24

IPO Status:

Private

Industries: